> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# CDRH Lists Changes Due to Pandemic
- URL: https://www.fdaweb.com/cdrh-lists-changes-due-to-pandemic/
- Published: 2020-03-24T12:00:00.000Z
- Updated: 2026-09-14T16:08:32.000Z
- Author: David McFarland
- Tags: Devices, #legacy-id-D5146400

In a letter to medical device establishments, CDRH says it has taken some steps to prioritize work that advances the nation’s response during the Covid-19 national emergency. The [letter](https://www.fda.gov/media/136383/download?utm%5Fcampaign=2020-03-24%20CDRH%20Issues%20Letter%20to%20Industry%20on%20COVID-19&utm%5Fmedium=email&utm%5Fsource=Eloqua) says the steps “seek to address the impact of the Covid-19 public health emergency on day-to-day operations in CDRH and in the medical device industry while ensuring that government and private sector efforts to respond to this national emergency receive the highest priority.” The Center steps address: 

- converting in-person meetings to teleconferences;
- processing of incoming documents; and
- extending response due dates for marketing applications currently on hold.

The letter also cites the emergency use authorization (EUA) for *in vitro* diagnostics to detect and/or diagnose the virus causing Covid-19 and strongly encourages applicants to submit pre-EUAs to discuss technologies that might help address the public health emergency.